In adolescents and adults, Szefler et al confirmed that the addition of FeNO measurement being an indicator of asthma Handle resulted in greater doses of ICS and prolonged-performing ?2 agonists than did standard guideline-based mostly treatment, and did not identify improvements in bronchial asthma signs and symptoms or lung functionality [one zer